Navigation Links
6-month follow-up diagnostic mammograms recommended for women with probably benign lesions
Date:5/8/2008

Radiologists can, with confidence, recommend a six-month follow-up diagnostic mammogram rather than an immediate biopsy for patients with probably benign breast lesions, a new study emphasizes.

The study found that six-month short-interval follow-up examinations had an 83% sensitivity, which is similar to the sensitivity of other diagnostic mammograms, said Erin J. Aiello Bowles, MPH, lead author of the study from the Group Health Center for Health Studies. High sensitivity means identifying a high proportion of true positives (actual cancer cases) and a low proportion of false negatives (cases mistakenly deemed benign).

The study included 45,007 initial short-interval follow-up mammograms. Short-interval follow-up mammograms are done to monitor for changes in probably benign breast lesions (findings seen on mammograms that have a very low probability of being cancer). Because the probability of cancer is so low, we dont want to put the patient through an unnecessary biopsy, which is an invasive procedure that increases both patient anxiety and medical costs, said Aiello Bowles. At the same time, we want to closely monitor these patients, because changes in probably benign lesions occasionally mean cancer, and we want to detect the cancers as early as possible, she said. In the study, 360 women with probably benign lesions were diagnosed with breast cancer within six months; and 506 women were diagnosed with cancer within 12 months (altogether about one in 100 of the probably benign lesions), Aiello Bowles said.

The Breast Imaging-Reporting and Data System (BI-RADS) recommends that women with a BI-RADS category 3 (probably benign) lesion get a six-month diagnostic mammogram, with follow-up continued for the next two to three years until long-term stability is demonstrated, said Dr. Edward Sickles, a coauthor and radiologist involved in the study from the University of California San Francisco. This study emphasizes that radi
'/>"/>

Contact: Necoya Tyson
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds
2. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
3. Methadone and systematic follow-up: the best solution for managing chronic pain
4. Catheter angiography may be an unnecessary follow-up to CT angiography
5. Conseco to Host Follow-Up Long-Term Care Conference Call
6. EPA Says Follow-Up Sampling Shows No PCB Risk at Park Ridge Elementary School
7. Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up
8. Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome
9. Follow-Up Exams Uncover More Iraq Vets With Emotional Woes
10. Study Challenges Colon Cancer Surgery Follow-Up
11. Follow-up imaging of benign-appearing incidental adrenal masses is unnecessary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Colo. (PRWEB) , ... July ... ... landscape relies on highly educated and motivated leaders with strong managerial expertise ... well they clearly communicate with patients, staff, providers, business partners, insurance companies, ...
(Date:7/7/2015)... ON (PRWEB) , ... July 07, 2015 , ... On ... is effective immediately and permits the use of gluten-free claims for gluten free oats ... prospect of expanding the Gluten-Free Certification Program (GFCP) to include gluten-free oat ...
(Date:7/7/2015)... ... 07, 2015 , ... CSG Government Solutions, a ... the Department of Vermont Health Access to provide Quality Assurance (QA) and Independent ... Integrated Contact Center System project. , Vermont is implementing a strategic approach to ...
(Date:7/6/2015)... Yorba Linda, CA (PRWEB) , ... July 06, ... ... human biology into the pre-clinical stages of drug discovery. iPSCs are generated from ... potential to differentiate into any cell type in the human body. , ...
(Date:7/6/2015)... ... July 06, 2015 , ... University of Pittsburgh ... guidelines for thyroid cancer testing to reflect newly available tests that better incorporate personalized ... and how to interpret thyroid cancer tests is published in the July issue of ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5
... Boards in Quality Measurement &,Improvement, PHILADELPHIA, ... new program for rewarding physicians based on ... Finance Committee has issued,recommendations to the Center ... alternatives for measuring and reporting performance, including,"registry-based" ...
... speech,earlier this week, Wal-Mart Chief Executive Officer Lee ... of offering pharmacy benefit manager,services. In response Bruce ... National Community Pharmacists Association (NCPA) issued the,following statement:, ... reformed. The current PBM business,model is one that ...
... Shaohua Xu, Florida Tech associate professor of biological sciences, has ... has earned a $150,000 grant from Space Florida to test ... Medicine and Occupational Health Branch. , He is also the ... Sciences Laboratory at Kennedy Space Center (KSC) and the research ...
... stem cells that differentiate into bone appears to cause regeneration ... strategy for osteoporosis, according to a report in the February ... by researchers from Massachusetts General Hospital (MGH) and the Harvard ... medication used to treat bone marrow cancer improved bone density ...
... N.J., Jan. 25 inVentiv Health, Inc.,(Nasdaq: ... its Fourth Quarter and,Full Year 2007 results and ... at 9:00 a.m. Eastern Standard Time., Conference ... please dial 800-358-8448 (Domestic) or,706-634-1367 (International). The conference ...
... Health, Inc. (Amex: OPK ),today announced the appointment ... its Board of Directors. The company also announced the,resignation ... to fill the vacancy created by Mr. Eichler,s resignation ... "The addition of Tom Beier and Rick Pfenniger ...
Cached Medicine News:Health News:Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI) 2Health News:NCPA Statement on Wal-Mart's Entry Into the Pharmacy Benefit Market 2Health News:Controversial theory of Alzheimer's origin funded 2Health News:Turning on adult stem cells may help repair bone 2Health News:inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th 2Health News:OPKO Health Announces Changes to Board of Directors 2Health News:OPKO Health Announces Changes to Board of Directors 3
(Date:7/7/2015)...  New study findings reveal that more complications occur ... for prostate cancer . Researchers from ... at the Canadian Urological Association annual meeting in ... that prostate cancer patients who undergo radiation therapy have ... procedures due to treatment complications. They analyzed over 60,000 ...
(Date:7/6/2015)... 6, 2015  EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... cancellation of its previously announced underwritten public offering of ... $0.87 per unit. Canaccord Genuity was ... was acting as co-manager for the offering. ...
(Date:7/6/2015)... 2015  Nitin Tandon, M.D., UTHealth neurosurgeon and ... Hermann Mischer Neuroscience Institute at the Texas ... technology into the skull of a 36-year-old epilepsy ... – the first time this procedure has been ... is a neurological condition that affects nearly three ...
Breaking Medicine Technology:New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 2New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 3New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 4EnteroMedics Inc. Announces Termination of Public Offering of Common Stock and Warrants 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 2Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 3Memorial Hermann Successfully Completes System's First NeuroPace RNS System Procedure for Epilepsy Patient 4
... WIRE via COMTEX News Network),-- Endo Pharmaceuticals ... Holdings Inc. (NASDAQ: ENDP), has presented results,from ... evaluating Frova (frovatriptan succinate) 2.5 mg,tablets as ... menstrual migraine (MM). The data demonstrated,that FROVA ...
... SALT LAKE CITY, UT, June 11, 2007 ... Genetics, Inc. (NASDAQ: MYGN) (<a target=,"_blank" href="http://www.myriad.com/">www.myriad.com ... comparison of a,"Staggered Start" and a "Randomized ... Staggered Start" clinical trial,design at the Alzheimer's ...
Cached Medicine Technology:Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 2Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 3Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 4Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 5Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 6Frova Phase III Study Data Demonstrates That Short-Term Prevention,Treatment Reduces Frequency and Severity of Menstrual Migraine 7Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5
SofLens Multi-Focal with unique Natra-Sight Optics designed to provide broad transition for near, intermediate and far vision, SofLens Multi-Focal lenses offer crisp, clear vision at all distances....
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
Bausch & Lomb SofLens59 contact lenses combine excellent performance, comfort and visual acuity providing daily wear for two week replacement....
... uses reflection mirrors to measure the ... after tumor removal or thyroid decompression. ... Naugle is easy to handle- with ... and plastic mounts that are placed ...
Medicine Products: